Tyra Biosciences to Present Groundbreaking Research at 2026 ASCO GU Symposium Tyra Biosciences, a leading biotechnology firm, will showcase its innovative research at the 2026 ASCO Genitourinary Cancers Symposium in San Francisco.

Tyra Biosciences to Present Groundbreaking Research at 2026 ASCO GU Symposium #United_States #San_Francisco #Tyra_Biosciences #FGFR_Biology #ASCO_GU

AVEO Oncology Reveals Key Findings on Tivozanib at ASCO GU 2025 Conference AVEO Oncology is set to showcase significant research findings on Tivozanib at the ASCO GU 2025 meeting in San Francisco. Key presentations will highlight advancements in renal cell carcinoma treatment.

AVEO Oncology Reveals Key Findings on Tivozanib at ASCO GU 2025 Conference #USA #San_Francisco #ASCO_GU #AVEO_Oncology #Tivozanib

Foresee Pharmaceuticals' Abstract Set for Presentation at ASCO GU Symposium 2025 Foresee Pharmaceuticals announces the acceptance of its abstract for the ASCO-GU Symposium 2025, highlighting advancements in prostate cancer treatment.

Foresee Pharmaceuticals' Abstract Set for Presentation at ASCO GU Symposium 2025 #USA #San_Francisco #Foresee_Pharmaceuticals #Prostate_Cancer #ASCO_GU

Caris Life Sciences to Showcase Innovative Cancer Research at 2025 ASCO GU Symposium Caris Life Sciences announces its participation in the 2025 ASCO GU Symposium, showcasing groundbreaking studies in cancer research, advancing precision medicine.

Caris Life Sciences to Showcase Innovative Cancer Research at 2025 ASCO GU Symposium #USA #San_Francisco #Caris_Life_Sciences #Precision_Oncology #ASCO_GU